Burl Concepts, Inc.

SAN DIEGO, CA · Founded 2013 · Medtech · Private

SONAS®, a rapid non-invasive brain imaging technology for evaluating neurological trauma and stroke

Claim this profile

Follows are private to you and power your alerts

Updated · burlconcepts.com

Sector
Medtech
Headquarters
SAN DIEGO, CA
Founded
2013
Latest Form D
$2.5M, Sep 2025
Total capital
$11.5M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$11.5M
6 Form D · last Sep 2025
14 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
9 pending · first 2021
Rank in peer group#337 of 1112

Capital timeline

201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $13.5M2nd Form D$3.1M3rd Form D$3.1M4th Form D$1.1M
201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $13.5M3rd Form D$3.1M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$2.5M
  • Private capital raisedForm D · SEC · 5th filing$1.6M
  • Private capital raisedForm D · SEC · 4th filing$1.1M
  • Private capital raisedForm D · SEC · 3rd filing$3.1M
  • Private capital raisedForm D · SEC · 2nd filing$3.1M
  • Offering registeredForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#337 · top 30%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Thilo HoelscherResearcherExecutive Officer, DirectorLinked by 1 patent
  • Benedikt KummerDirectorNamed in SEC Form D filings
  • Christian BuckleyExecutive OfficerNamed in SEC Form D filings
  • James BraileanExecutive Officer, DirectorNamed in SEC Form D filings
  • Jim BraileanExecutive Officer, DirectorNamed in SEC Form D filings
  • Oppel GreeffDirectorNamed in SEC Form D filings
Show all 9 people
  • Peter van der SluisExecutive Officer, DirectorNamed in SEC Form D filings
  • Thomas DoyleExecutive OfficerNamed in SEC Form D filings
  • Will MartinDirectorNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 13
Show all 13 patent records
  • Systems and Methods for Non-Invasive Measurement of Intracranial PressureJan 22, 2026 · Application 19344237Pending
  • Systems and Methods for Non-Invasive Measurement of Intracranial PressureOct 21, 2025 · US 12,446,849Granted
  • Portable Ultrasound DeviceAug 21, 2025 · Application 19199367Pending
  • Portable Ultrasound DeviceAug 5, 2025 · US 12,376,827Granted
  • Portable Ultrasound DeviceOct 31, 2023 · US 11,801,036Granted
  • Portable Ultrasound DeviceMay 18, 2021 · US 11,006,924Granted
  • Ultrasound Gel Module AssembliesAug 2, 2018 · Application 15883880Pending
  • Portable Ultrasound DeviceApplication PCTUS2018024204Pending
  • Ultrasound Gel Module AssembliesApplication PCTUS2018015944Pending
  • Apparatuses and Methods for Generating Diagnostic Support DataApplication 62476638Pending
  • Systems and Methods for Non-Invasive Measurement of Intracranial PressureApplication 63483190Pending
  • Ultrasound Gel Module AssembliesApplication 62452253Pending
  • Systems and Methods for Non-Invasive Measurement of Intracranial PressureApplication 63578621Pending
  • DATASHAPES, LLCSimilar federal contract value in Medtech · null in contracts
  • LUCIDITY MEDICAL, LLCSimilar federal contract value in Medtech · null in contracts
  • Biolectrics LLCSimilar federal contract value in Medtech · null in contracts
  • BIOMERICA INCSimilar federal contract value in Medtech · null in contracts
  • BRUKER CORPSimilar federal contract value in Medtech · null in contracts
  • Immy Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .